Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...

Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the ...

The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...

Institutions like OMRF have had almost unbroken bipartisan support as a national biomedical research policy. Breaking it would be irreversibly tragic.

Traditionally, COVID vaccines have been delivered via injections. According to the Cincinnati Children’s Hospital Medical ...

For decades, one of the world’s most contagious diseases was considered eradicated in the U.S. But now measles is roaring ...

Look inside a brain cell with Huntington's disease or ALS and you are likely to find RNA clumped together. These solid-like clusters, thought to be irreversible, can act as sponges that soak up ...

NPR's Pien Huang speaks with pediatrician Alexandra Cvijanovich and Professor Jason L. Schwartz about trying to shore up trust about vaccines.

As mRNA-based treatments evolve, optimizing capping strategies becomes critical for enhancing stability, translation efficiency, and potency. This comparative analysis of TriLink’s CleanCap® ...

Post-authorisation safety monitoring can characterise the safety profiles of mRNA-based COVID-19 vaccines in large and heterogeneous populations. 6 Phased administration of COVID-19 vaccines in the ...

“mRNA vaccines have a couple of key benefits or features that really stand out compared to other vaccine platforms,” he said. “One, they can be generated very, very quickly.